Skip to main content
SpringerLink
Log in

Uterine Cervix Cancer

  • Chapter
  • First Online:
Hypofractionated and Stereotactic Radiation Therapy

  • 1053 Accesses

Abstract

While early-stage cervical cancer can be managed surgically, locally advanced cervical cancer is treated with definitive EBRT with concurrent chemotherapy and brachytherapy. High-dose rate brachytherapy is a technique that enables delivery of high-dose, hypofractionated radiotherapy directly to the cervical tumor. Advances in brachytherapy include 3D imaging, which enables delineation of adjacent organs at risk (CT or MRI) and the cervical tumor (MRI). In this chapter, we review the usage of high-dose rate (HDR) intracavitary brachytherapy in the treatment of cervical carcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Han K, Milosevic M, Fyles A, Pintilie M, Viswanathan AN. Trends in the utilization of brachytherapy in Cervical Cancer in the United States. Int J Radiat Oncol. 2013;87(1):111–9. https://doi.org/10.1016/j.ijrobp.2013.05.033.

    Article  Google Scholar 

  2. Tanderup K, Fokdal LU, Sturdza A, et al. Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer. Radiother Oncol. 2016;120:441–6. https://doi.org/10.1016/j.radonc.2016.05.014.

    Article  PubMed  Google Scholar 

  3. Fyles A, Keane TJ, Barton M, Simm J. The effect of treatment duration in the local control of cervical cancer. Radiother Oncol J Eur Soc Ther Radiol Oncol. 1992;25:273–9.

    Article  CAS  Google Scholar 

  4. Viswanathan AN, Beriwal S, De Los Santos JF, et al. American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: high-dose-rate brachytherapy. Brachytherapy. 2012;11:47–52. https://doi.org/10.1016/j.brachy.2011.07.002.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Haie-Meder C, Potter R, Van Limbergen E, et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol. 2005;74:235–45. https://doi.org/10.1016/j.radonc.2004.12.015.

    Article  PubMed  Google Scholar 

  6. Viswanathan AN, Thomadsen B, American Brachytherapy Society Cervical Cancer Recommendations Committee; American Brachytherapy Society. American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix Part I: general principles. Brachytherapy. 2012;11:33–46. https://doi.org/10.1016/j.brachy.2011.07.003.

    Article  PubMed  Google Scholar 

  7. Potter R, Haie-Meder C, Van Limbergen E, et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol. 2006;78:67–77. https://doi.org/10.1016/j.radonc.2005.11.014.

    Article  PubMed  Google Scholar 

  8. Small W, Beriwal S, Demanes DJ, et al. American Brachytherapy Society consensus guidelines for adjuvant vaginal cuff brachytherapy after hysterectomy. Brachytherapy. 2012;11(1):58–67. https://doi.org/10.1016/j.brachy.2011.08.005.

    Article  PubMed  Google Scholar 

  9. Higginson DS, Morris DE, Jones EL, Clarke-Pearson D, Varia MA. Stereotactic body radiotherapy (SBRT): technological innovation and application in gynecologic oncology. Gynecol Oncol. 2011;120:404–12. https://doi.org/10.1016/j.ygyno.2010.11.042.

    Article  PubMed  Google Scholar 

  10. Halle JS, Rosenman JG, Varia MA, Fowler WC, Walton LA, Currie JL. 1000 cGy single dose palliation for advanced carcinoma of the cervix or endometrium. Int J Radiat Oncol Biol Phys. 1986;12(11):1947–50.

    Article  CAS  PubMed  Google Scholar 

  11. Boulware RJ, Caderao JB, Delclos L, Wharton JT, Peters LJ. Whole pelvis megavoltage irradiation with single doses of 1000 rad to palliate advanced gynecologic cancers. Int J Radiat Oncol Biol Phys. 1979;5(3):333–8.

    Article  CAS  PubMed  Google Scholar 

  12. Chafe W, Fowler WC, Currie JL, Davis ML, Walton LA, Montana G. Single-fraction palliative pelvic radiation therapy in gynecologic oncology: 1,000 rads. Am J Obstet Gynecol. 1984;148(5):701–5.

    Article  CAS  PubMed  Google Scholar 

  13. Mazeron R, Fokdal LU, Kirchheiner K, et al. Dose-volume effect relationships for late rectal morbidity in patients treated with chemoradiation and MRI-guided adaptive brachytherapy for locally advanced cervical cancer: results from the prospective multicenter EMBRACE study. Radiother Oncol. 2016;120:412–9. https://doi.org/10.1016/j.radonc.2016.06.006.

    Article  PubMed  Google Scholar 

  14. Kirchheiner K, Nout RA, Lindegaard JC, et al. Dose–effect relationship and risk factors for vaginal stenosis after definitive radio(chemo)therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE study. Radiother Oncol. 2016;118(1):160–6. https://doi.org/10.1016/j.radonc.2015.12.025.

    Article  PubMed  Google Scholar 

  15. Liberrman D, Mehus B, Eliott S. Urinary adverse effects of pelvic radiotherapy. Transl Androl Urol. 2014;3(2):186–95.

    Google Scholar 

  16. Liu R, Wang X, Tian JH, et al. High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer. Cochrane Database Syst Rev. 2014;10:CD007563. https://doi.org/10.1002/14651858.CD007563.pub3.

    Article  Google Scholar 

  17. Eifel PJ, Winter K, Morris M, et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of Radiation Therapy Oncology Group trial (RTOG) 90-01. J Clin Oncol. 2004;22(5):872–80. https://doi.org/10.1200/JCO.2004.07.197.

    Article  PubMed  Google Scholar 

  18. Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med. 1999;340:1144–53. https://doi.org/10.1056/NEJM199904153401502.

    Article  PubMed  CAS  Google Scholar 

  19. Jorcano S, Molla M, Escude L, et al. Hypofractionated extracranial stereotactic radiotherapy boost for gynecologic tumors: a promising alternative to high-dose rate brachytherapy. Technol Cancer Res Treat. 2010;9:509–14.

    Article  PubMed  Google Scholar 

  20. Kunos CA, Brindle J, Waggoner S, et al. Phase II clinical trial of robotic stereotactic body radiosurgery for metastatic gynecologic malignancies. Front Oncol. 2012;2:181. https://doi.org/10.3389/fonc.2012.00181.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Dewas S, Bibault J, Mirabel X, et al. Robotic image-guided reirradiation of lateral pelvic recurrences: preliminary results. Radiat Oncol. 2011;6(1):77. https://doi.org/10.1186/1748-717X-6-77.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Choi CW, Cho CK, Yoo SY, et al. Image-guided stereotactic body radiation therapy in patients with isolated para-aortic lymph node metastases from uterine cervical and corpus cancer. Int J Radiat Oncol Biol Phys. 2009;74:147–53. https://doi.org/10.1016/j.ijrobp.2008.07.020.

    Article  PubMed  Google Scholar 

  23. Mesko S, Sandler K, Cohen J, Konecny G, Steinberg M, Kamrava M. Clinical outcomes for stereotactic ablative radiotherapy in oligometastatic and oligoprogressive gynecological malignancies. Int J Gynecol Cancer. 2017;27(2):403–8. https://doi.org/10.1097/IGC.0000000000000869.

    Article  PubMed  Google Scholar 

  24. Badakh DK, Grover AH. Reirradiation with high-dose-rate remote afterloading brachytherapy implant in patients with locally recurrent or residual cervical carcinoma. J Cancer Res Ther. 2009;5:24–30.

    Article  PubMed  Google Scholar 

  25. Zolciak-Siwinska A, Bijok M, Jonska-Gmyrek J, et al. HDR brachytherapy for the reirradiation of cervical and vaginal cancer: analysis of efficacy and dosage delivered to organs at risk. Gynecol Oncol. 2014;132:93–7. https://doi.org/10.1016/j.ygyno.2013.10.018.

    Article  PubMed  Google Scholar 

  26. Mabuchi S, Takahashi R, Isohashi F, et al. Reirradiation using high-dose-rate interstitial brachytherapy for locally recurrent cervical cancer: a single institutional experience. Int J Gynecol Cancer. 2014;24:141–8. https://doi.org/10.1097/IGC.0000000000000028.

    Article  PubMed  Google Scholar 

  27. Kim DH, Lee JH, Ki YK, et al. Short-course palliative radiotherapy for uterine cervical cancer. Radiat Oncol J. 2013;31:216–21. https://doi.org/10.3857/roj.2013.31.4.216.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Grigsby PW, Portelance L, Williamson JF. High dose ratio (HDR) cervical ring applicator to control bleeding from cervical carcinoma. Int J Gynecol Cancer. 2002;12(1):18–21.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of North Carolina School of Medicine, Chapel Hill, NC, USA

    Brittaney-Belle E. Gordon

  2. Department of Radiation Oncology, University of North Carolina School of Medicine, Chapel Hill, NC, USA

    Orit Kaidar-Person, Mahesh Varia & Ashley A. Weiner

  3. Oncology Institute Radiation Oncology and Neuro-Oncology Unit, Rambam Medical Center, Haifa, Israel

    Orit Kaidar-Person

Authors
  1. Brittaney-Belle E. Gordon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Orit Kaidar-Person
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mahesh Varia
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ashley A. Weiner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ashley A. Weiner .

Editor information

Editors and Affiliations

  1. Department of Radiation Oncology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA

    Orit Kaidar-Person

  2. Department of Radiation Oncology, University of North Carolina, Chapel Hill, North Carolina, USA

    Ronald Chen

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Gordon, BB.E., Kaidar-Person, O., Varia, M., Weiner, A.A. (2018). Uterine Cervix Cancer. In: Kaidar-Person, O., Chen, R. (eds) Hypofractionated and Stereotactic Radiation Therapy. Springer, Cham. https://doi.org/10.1007/978-3-319-92802-9_26

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-92802-9_26

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-92800-5

  • Online ISBN: 978-3-319-92802-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation